Markets |
Wall Street rises as investors eye rate hike delay, oil up
BY SINEAD CAREW
DJ: 16,776.43 +304.06 NAS: 4,781.26
+73.49 S&P: 1,987.05
+35.69
REUTERS/BRENDAN
MCDERMID
U.S. stocks jumped on Monday, with the S&P 500 rising for the fifth day in a row, as
rising oil prices boosted energy stocks and investors bet the Federal Reserve
would not raise interest rates this year.
The S&P's five-day
rise of 5.6 percent was its best five days back to late 2011.
Monday saw strong increases in industrials, energy, telecommunications and
materials stocks.
Friday's U.S. nonfarm
payrolls report for September showed job growth slowed in the last three
months, increasing prospects that the era of near-zero interest rates will
continue for a while yet.
"Wall Street's favorite movie is nightmare on your street.
The missed unemployment number means the Fed is probably going to hold
longer," said Stephen Massocca, Chief Investment Officer at Wedbush Equity
Management LLC in San Francisco.
The Fed, which has not raised interest rates since June 2006,
kept its benchmark rate unchanged in September, citing an uncertain global
economic outlook and volatile markets.
Traders are pricing in only a 31-percent chance of a December
hike, down from 44 percent before the jobs report, according to CME Group's
FedWatch program.
The Dow Jones industrial
average .DJI rose 304.06 points, or 1.85 percent, to
16,776.43, theS&P 500 .SPX gained 35.69 points, or 1.83 percent,
to 1,987.05 and the Nasdaq Composite.IXIC added 73.49 points, or 1.56 percent, to
4,781.26.
All 10 major S&P sectors closed higher. The top boost for
the industrial index's .SPLRCI 3-percent rise was GE (GE.N). It
jumped 5.3 percent after Nelson Peltz's Trian Fund Management disclosed a
roughly 1-percent stake..
Energy stocks .SPNY jumped
3 percent, boosted by a 1.6 percent rise in U.S. crude oilprices. They
were helped by a rally in U.S. gasoline and Russia's willingness to meet other
major oil producers to discuss the market. [O/R]
The Nasdaq biotechnology index .NBI fell 0.7
percent, breaking three days of gains. The index was crushed in the previous
eight sessions on investor worries about drug price regulations.
The United States and other Pacific Rim countries reached a
trade liberalization deal which fell short industry group expectations for drug
patent protection.
With third-quarter earnings season starting this week, investors
are beginning to factor in what could be the biggest fall in profits for S&P 500 companies in six years. Wall Street expectsS&P 500 companies to report a 4.2 percent
decline in earnings, according to Thomson Reuters data.
Advancing issues outnumbered declining ones on the NYSE by 2,734
to 373, for a 7.33-to-1 ratio; on the Nasdaq,
2,187 issues rose and 627 fell for a 3.49-to-1 ratio favoring advancers.
The S&P 500 posted 9 new 52-week highs and no new
lows; the Nasdaq recorded 43 new highs and 33 lows.
Volume was strong with
about 7.86 billion shares changing hands on U.S. exchanges, above the 7.32 billion
average for the previous 20 sessions, according to Thomson Reuters data.
No comments:
Post a Comment